REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
REGENXBIO priced a public offering of 10,003,889 shares of common stock at $9.00 per share and 1,111,111 pre-funded warrants at $8.9999 per warrant. The offering is expected to generate approximately $100.0 million in gross proceeds before expenses, with a closing date set for July 20, 2026. Morgan Stanley, J.P.
Key figures
- Deal Value Usd
- 100000000
- Offering Price
- 9
- Shares Offered
- 10003889
- Warrant price
- 8.9999
- Greenshoe shares
- 1667250
- Pre funded warrants
- 1111111
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.